Stay updated on Adaptive TKI Therapy in Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Adaptive TKI Therapy in Thyroid Cancer Clinical Trial page.

Latest updates to the Adaptive TKI Therapy in Thyroid Cancer Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 with no visible changes to core study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA new 'Locations' section lists Florida as a site, replacing the former 'Florida Locations' entry; the 'HHS Vulnerability Disclosure' link was removed.SummaryDifference0.2%

- Check55 days agoChange DetectedRevision: v3.2.0 updated to v3.3.2. No visible changes to study content or page structure are evident in the screenshot.SummaryDifference0.0%

- Check62 days agoChange DetectedRemoved the government funding lapse notice from the page. The study details, eligibility criteria, and outcomes sections remain unchanged.SummaryDifference0.3%

- Check76 days agoChange DetectedNo significant updates were detected to the study page between versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check105 days agoChange DetectedMajor update: publishing a government funding/status notice and upgrading to v3.2.0; removal of specific thyroid cancer resources (Medullary and Differentiated thyroid carcinoma) from the Genetic and Rare Diseases Information Center.SummaryDifference3%

Stay in the know with updates to Adaptive TKI Therapy in Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adaptive TKI Therapy in Thyroid Cancer Clinical Trial page.